Wow some true believers out there and very sensitive to the cautious analysis I passed on - no I am not a paid saboteur just a humble Medico with some understanding of the medical aspects but little or no financial background, I felt the analyst raised some good points about the capital raising issues and possible dilution of value and the long process of getting to market. I don't believe there is enough upside in value in the GVHD cohort. From memory the last report I read on reservacor last year from the company they didn't quite reach the FDA requirement for the 18 month point but I can't find the article. I do believe the back pain issue will be the big money earner. Personally I would leap for joy if it happens. Please take this note of caution as itis intended To resort to insults and hyperbole is not mature. I believe there are lots of small investors with MSB so remember Warren Buffets maxim "first consider the downside"
MSB
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9994 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 94676 | 9 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |